KaracaBEsinFKÖzdemirETiryakiMMÖzdemirSKırışT. The systemic immune-inflammation Index and predicting cardiac implantable electronic device infections. Angiology. 2024;75:15-21.
2.
Blomström-LundqvistCTraykovVErbaPA, et al.European heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the heart rhythm society (HRS), the Asia Pacific heart rhythm society (APHRS), the Latin American heart rhythm society (LAHRS), international society for cardiovascular infectious diseases (ISCVID) and the European society of clinical microbiology and infectious diseases (ESCMID) in collaboration with the European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2020;41:2012-32.
3.
WilkoffBLBorianiGMittalS, et al.Impact of cardiac implantable electronic device infection: a clinical and economic analysis of the WRAP-IT trial. Circ Arrhythm Electrophysiol. 2020;13:e008280.
4.
OlsenTJørgensenODNielsenJCThøgersenAMPhilbertBTJohansenJB. Incidence of device-related infection in 97750 patients: clinical data from the complete Danish device-cohort (1982–2018). Eur Heart J. 2019;40:1862-9.
5.
PolyzosKAKonstanteliasAAFalagasME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17:767-77.
6.
SteinwenderCLercherPSchukroC, et al.State of the art: leadless ventricular pacing: a national expert consensus of the Austrian Society of Cardiology. J Intervent Card Electrophysiol. 2020;57:27-37.
7.
SławińskiGKempaMPrzybylskiA. Prevention of cardiac implantable electronic device infections: a review. Rev Cardiovasc Med2023;24:176.
